Market Overview

Citigroup Maintains Buy, $46 PT on Agilent Technologies on Growth Drivers

Related A
Stocks To Watch For September 18, 2014
Top 4 NYSE Stocks In The Medical Laboratories & Research Industry With The Highest Dividend Yield

Citigroup reiterates its Buy rating and $46 price target on Agilent Technologies (NYSE: A) following a meeting with the company's CEO

Citigroup says, "On Friday (6/15), we hosted Agilent's CEO and CFO as part of our 2012 Life Science Tools CEO Conf Call Series. Mgmt highlighted that recent macroeconomic pressures have yet to improve so far in 2012, but despite those headwinds, key growth drivers in each business segment should enable a positive F2H12. We recently initiated Agilent with a Buy rating and remain positive on Agilent's longer-term opportunity in the life science tools space on emerging market exposure, margin expansion opportunities, and strong cash management."

A closed at $40.01 on Friday.

Latest Ratings for A

DateFirmActionFromTo
Sep 2014Morgan StanleyInitiates Coverage onEqualweight
May 2014Bank of AmericaMaintainsBuy
May 2014JefferiesMaintainsBuy

View More Analyst Ratings for A
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Price Target Reiteration Pre-Market Outlook Analyst Ratings

 

Related Articles (A)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters